About
Uscom Limited is an Australian medical technology company based in Sydney, listed on the ASX. The company specializes in developing, manufacturing, and marketing non-invasive cardiovascular and pulmonary medical devices. Uscom is dedicated to enhancing clinical care and patient outcomes through innovative technology. The company offers three main product suites: the USCOM 1A Advanced Hemodynamic Monitor, which uses Doppler ultrasound to assess cardiovascular function; the Uscom BP+ Central Blood Pressure Monitor, which measures central blood pressure non-invasively; and the Uscom SpiroSonic Suite, a range of digital ultrasonic spirometers for pulmonary function testing. These devices are designed for use in hospitals and by clinicians specializing in cardiovascular and pulmonary care. Uscom is committed to research and development, aiming to maintain its leadership in non-invasive monitoring solutions and to make a significant impact on global healthcare.
Technologies
Keywords
Company Information
- Employees35
- Founded1999
- Annual Revenue$1685000
Location
66 Clarence St, Sydney, New South Wales, Australia, 2000